お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
539048

医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場:市場機会分析、市場シェア、将来予測

Global Cognitive Assessment and Training in Healthcare Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

出版日: | 発行: Occams Business Research & Consulting Pvt. Ltd. | ページ情報: 英文 190 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=108.90円
医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場:市場機会分析、市場シェア、将来予測
出版日: 2017年07月18日
発行: Occams Business Research & Consulting Pvt. Ltd.
ページ情報: 英文 190 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場を取り上げ、市場成長促進要因、阻害要因、市場機会、市場競争状況等を包括的に検証し、現在の市場シナリオ分析と今後の予測を行っています。

第1章 序論

  • エグゼクティブ・サマリー
  • 市場評価手法

第2章 市場概要

  • 医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場:進化と変化
  • 市場の定義および範囲
  • 業界構造
  • 法規制の枠組み
  • 全体市場分析
    • 重要な調査結果主要5項目
    • 市場機会上位5項目
    • 主要5社
    • トップ3競合戦略
  • 市場見積分析
  • 戦略的分析
    • 投資 vs. 導入モデル
    • 全方位業界分析
    • Porterのファイブフォースモデル
    • シーソー分析
    • 価格分析
    • 消費者分析および主要購入基準
  • 市場競争分析
    • 重要戦略と分析
    • 市場シェアおよびトップ企業分析
  • 戦略的提言および重要な結論事項
    • 地域別投資機会
    • 新たな用途に向けた市場機会
    • 最速の成長を遂げている分野への投資機会

第3章 市場の決定要素

  • 市場成長促進要因
  • 市場成長阻害要因
  • 市場機会
  • 市場の課題

第4章 市場分類

  • 医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場の評価法タイプ別分析
    • 市場の定義および範囲
    • 決定の裏付けとなるデータベースおよび評価手法
    • 市場分野間の比較分析
    • 市場機会マトリクス
    • 市場分類
  • 医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場の提供品目別分析
    • 市場分類
  • 医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場の適用分野別分析
    • 市場分類

第5章 市場競争状況

  • 主要戦略
  • トップ企業10社の分析

第6章 医療・健康管理分野における認知機能評価およびトレーニングツールの世界市場び地域別分析

  • 決定の裏付けとなるデータベースおよび評価手法
  • 市場分野間の比較分析
  • 市場機会マトリクス
  • 地域市場別分類
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 主要企業プロファイル

目次
Product Code: HHE-6640817

The global cognitive assessment and training in healthcare is growing with a CAGR of around 33.8% during the forecast period (2016-2023). Cognitive assessment and training is a suitable assessment of one's psychological behaviour. It also accesses speed of information processing. Cognitive assessment and training aids an individual in defining, assessing and focusing on specific needs more proficiently. The analysis subsequently cognitive assessment can be valuable for several functions such as early detection of dementia and cognitive training of individuals among population. The major driving factor of the global cognitive assessment and training in healthcare are rising aging population, brain fitness awareness and development in technology. Time restraints in emerging clinically validated brain fitness software and stringent government regulation are the major restraining factor of the global cognitive assessment and training in healthcare market. Increasing use of modern cognitive assessment and training tools and increase in the demand for the improved brain fitness is the major opportunity for the market.

Increasing use of modern cognitive assessment and training tools drives the global cognitive assessment and training in healthcare, such as advanced Neuro-diagnostic devices are likely to access cognitive functions in an effective manner. In the year 2015 United States food and drug association approved new and recently tools to assess and monitor cognition objective to make in office assessment simpler and faster, such as Cognivue by Cerebral Assessment Systems Inc. which is a computer based tool designed to easy access, monitor and measure brain function to detect early sign of dementia. According to the dementia statistics organization in the United Kingdom around one million people have dementia by the year 2025. The rise in the dementia is also acting as a major driver of the market.

On the basis of segmentation, the global cognitive assessment and training in healthcare market is segmentation into assessment type, component and application. The assessment type is sub segmented into pen and paper assessment, hosted assessment, and biometrics assessment. The component segmented is further divided into solution and services. The application segment is sub segmented into clinical trials, screening & diagnostic, brain training, and academic research and others. Screening tests are employed for the detection of cognitive impairment. Early detection of cognitive disorders permits patients to yield timely action and access to the available non-drug and drug treatments that may recover cognition.

On the basis of the geography, North America is anticipated to have be the major market share and dominate the market during in the year 2016. As the large number of vendors offers cognitive assessment and training in healthcare, owing to rising increased awareness among population and increasing demand for enhancing neuroplasticity of brain. Moreover, according to the Alzheimer's Association organization, in America Alzheimer's disease is growing with a fast pace, it is estimated that around 5.5 million Americans are living with Alzheimer dementia in the year 2017. The major player of the global cognitive assessment and training in healthcare market are Bracket, Cambridge Cognition Ltd, Cogstate Ltd, Medavante Inc, Neurocog Trials, Pearson Assessment, Quest diagnostics, Savonix, Cognifit, ERT clinical and others. These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch in the global cognitive assessment and training in healthcare market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION AND SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. PRICING ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING AGING POPULATION
    • 3.1.2. BRAIN FITNESS AWARENESS
    • 3.1.3. DEVELOPMENT IN TECHNOLOGY
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. TIME RESTRAINT IN EMERGING CLINICALLY VALIDATED BRAIN FITNESS SOFTWARE
    • 3.2.2. STRINGENT GOVERNMENT REGULATIONS
  • 1.1. MARKET OPPORTUNITIES
    • 1.1.1. INCREASING USE OF MODERN COGNITIVE ASSESSMENT AND TRAINING TOOLS
    • 1.1.2. INCREASE IN DEMAND FOR IMPROVED BRAIN FITNESS
  • 1.2. MARKET CHALLENGES
    • 1.2.1. SUITABILITY OF THE COGNITIVE ASSESSMENT PROCESS
    • 1.2.2. AWARENESS ABOUT BRAIN FITNESS

2. MARKET SEGMENTATION

  • 2.1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY ASSESSMENT TYPE
    • 2.1.1. MARKET DEFINITION AND SCOPE
    • 2.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 2.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 2.1.4. OPPORTUNITY MATRIX
    • 2.1.5. MARKET SEGMENTATION
      • 2.1.5.1. PEN AND PAPER-ASSESSMENT
        • 2.1.5.1.1. APPLICATIONS
        • 2.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 2.1.5.1.5. KEY CONCLUSIONS
      • 2.1.5.2. HOSTED ASSESSMENT
        • 2.1.5.2.1. APPLICATIONS
        • 2.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 2.1.5.2.5. KEY CONCLUSIONS
      • 2.1.5.3. BIOMETRICS ASSESSMENT
        • 2.1.5.3.1. APPLICATIONS
        • 2.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 2.1.5.3.5. KEY CONCLUSIONS
  • 2.2. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY BY COMPONENT
    • 2.2.1. MARKET DEFINITION AND SCOPE
    • 2.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 2.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 2.2.4. OPPORTUNITY MATRIX
    • 2.2.5. MARKET SEGMENTATION
      • 2.2.5.1. SOLUTION
        • 2.2.5.1.1. APPLICATIONS
        • 2.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 2.2.5.1.5. KEY CONCLUSIONS
        • 2.2.5.1.6. SUB SEGMENT
          • 2.2.5.1.6.1. ASSESSMENT
          • 2.2.5.1.6.2. DATA MANAGEMENT
          • 2.2.5.1.6.3. DATA MANAGEMENT
          • 2.2.5.1.6.4. DATA ANALYSIS AND REPORTING
          • 2.2.5.1.6.5. OTHERS
      • 2.2.5.2. SERVICES
        • 2.2.5.2.1. APPLICATIONS
        • 2.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 2.2.5.2.5. KEY CONCLUSIONS
        • 2.2.5.2.6. SUB SEGMENT
          • 2.2.5.2.6.1. TRAINING AND SUPPORT
          • 2.2.5.2.6.2. CONSULTING
  • 2.3. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY APPLICATION
    • 2.3.1. MARKET DEFINITION AND SCOPE
    • 2.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 2.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 2.3.4. OPPORTUNITY MATRIX
    • 2.3.5. MARKET SEGMENTATION
      • 2.3.5.1. CLINICAL TRIALS
        • 2.3.5.1.1. APPLICATIONS
        • 2.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 2.3.5.1.5. KEY CONCLUSIONS
      • 2.3.5.2. SCREENING AND DIAGNOSTICS
        • 2.3.5.2.1. APPLICATIONS
        • 2.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 2.3.5.2.5. KEY CONCLUSIONS
      • 2.3.5.3. BRAIN TRAINING
        • 2.3.5.3.1. APPLICATIONS
        • 2.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 2.3.5.3.5. KEY CONCLUSIONS
      • 2.3.5.4. ACADEMIC RESEARCH
        • 2.3.5.4.1. APPLICATIONS
        • 2.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
        • 2.3.5.4.5. KEY CONCLUSIONS
      • 2.3.5.5. OTHERS
        • 2.3.5.5.1. APPLICATIONS
        • 2.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 2.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 2.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
        • 2.3.5.5.5. KEY CONCLUSIONS

3. COMPETITIVE LANDSCAPE

  • 3.1. KEY STRATEGIES
    • 3.1.1. LIST OF MERGERS & ACQUISITION
    • 3.1.2. LIST OF JOINT VENTURES
    • 3.1.3. LIST OF PRODUCT LAUNCHES
    • 3.1.4. LIST OF PARTNERSHIPS
  • 3.2. TOP 10 COMPANY ANALYSIS

4. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY REGION

  • 4.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 4.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. GEOGRAPHIC SEGMENTATION
    • 4.4.1. NORTH AMERICA
      • 4.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 4.4.1.2. TOP COUNTRY ANALYSIS
        • 4.4.1.2.1. U.S.
          • 4.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
          • 4.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.1.2.1.3. KEY CONCLUSIONS
        • 4.4.1.2.2. CANADA
          • 4.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.1.2.2.3. KEY CONCLUSIONS
    • 4.4.2. EUROPE
      • 4.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 4.4.2.2. TOP COUNTRY ANALYSIS
        • 4.4.2.2.1. UK
          • 4.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.1.3. KEY CONCLUSIONS
        • 4.4.2.2.2. FRANCE
          • 4.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.2.3. KEY CONCLUSIONS
        • 4.4.2.2.3. GERMANY
          • 4.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.3.3. KEY CONCLUSIONS
        • 4.4.2.2.4. SPAIN
          • 4.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.4.3. KEY CONCLUSIONS
        • 4.4.2.2.5. ITALY
          • 4.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.5.3. KEY CONCLUSIONS
        • 4.4.2.2.6. REST OF EUROPE
          • 4.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.2.2.6.3. KEY CONCLUSIONS
    • 4.4.3. ASIA PACIFIC
      • 4.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 4.4.3.2. TOP COUNTRY ANALYSIS
        • 4.4.3.2.1. CHINA
          • 4.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.1.3. KEY CONCLUSIONS
        • 4.4.3.2.2. INDIA
          • 4.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.2.3. KEY CONCLUSIONS
        • 4.4.3.2.3. JAPAN
          • 4.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.3.3. KEY CONCLUSIONS
        • 4.4.3.2.4. SOUTH KOREA
          • 4.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.4.3. KEY CONCLUSIONS
        • 4.4.3.2.5. AUSTRALIA
          • 4.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.5.3. KEY CONCLUSIONS
        • 4.4.3.2.6. REST OF ASIA PACIFIC
          • 4.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.3.2.6.3. KEY CONCLUSIONS
    • 4.4.4. ROW
      • 4.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 4.4.4.2. TOP COUNTRY ANALYSIS
        • 4.4.4.2.1. LATIN AMERICA
          • 4.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.4.2.1.3. KEY CONCLUSIONS
        • 4.4.4.2.2. MIDDLE EAST & AFRICA
          • 4.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 4.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 4.4.4.2.2.3. KEY CONCLUSIONS

5. COMPANY PROFILES

  • 5.1. BRACKET
    • 5.1.1. OVERVIEW
    • 5.1.2. PRODUCT PORTFOLIO
    • 5.1.3. KEY INNOVATION/FOCUS SECTOR
    • 5.1.4. STRATEGIC INITIATIVES
    • 5.1.5. SCOT ANALYSIS
    • 5.1.6. STRATEGIC ANALYSIS
  • 5.2. BRAIN RESOURCE COMPANY.
    • 5.2.1. OVERVIEW
    • 5.2.2. PRODUCT PORTFOLIO
    • 5.2.3. KEY INNOVATION/FOCUS SECTOR
    • 5.2.4. STRATEGIC INITIATIVES
    • 5.2.5. SCOT ANALYSIS
    • 5.2.6. STRATEGIC ANALYSIS
  • 5.3. CAMBRIDGE COGNITION LTD
    • 5.3.1. OVERVIEW
    • 5.3.2. PRODUCT PORTFOLIO
    • 5.3.3. KEY INNOVATION/FOCUS SECTOR
    • 5.3.4. STRATEGIC INITIATIVES
    • 5.3.5. SCOT ANALYSIS
    • 5.3.6. STRATEGIC ANALYSIS
  • 5.4. COGSTATE LTD.
    • 5.4.1. OVERVIEW
    • 5.4.2. PRODUCT PORTFOLIO
    • 5.4.3. KEY INNOVATION/FOCUS SECTOR
    • 5.4.4. STRATEGIC INITIATIVES
    • 5.4.5. SCOT ANALYSIS
    • 5.4.6. STRATEGIC ANALYSIS
  • 5.5. COGNIFIT
    • 5.5.1. OVERVIEW
    • 5.5.2. PRODUCT PORTFOLIO
    • 5.5.3. KEY INNOVATION/FOCUS SECTOR
    • 5.5.4. STRATEGIC INITIATIVES
    • 5.5.5. SCOT ANALYSIS
    • 5.5.6. STRATEGIC ANALYSIS
  • 5.6. ERT CLINICAL
    • 5.6.1. OVERVIEW
    • 5.6.2. PRODUCT PORTFOLIO
    • 5.6.3. KEY INNOVATION/FOCUS SECTOR
    • 5.6.4. STRATEGIC INITIATIVES
    • 5.6.5. SCOT ANALYSIS
    • 5.6.6. STRATEGIC ANALYSIS
  • 5.7. LEARNINGRX
    • 5.7.1. OVERVIEW
    • 5.7.2. PRODUCT PORTFOLIO
    • 5.7.3. KEY INNOVATION/FOCUS SECTOR
    • 5.7.4. STRATEGIC INITIATIVES
    • 5.7.5. SCOT ANALYSIS
    • 5.7.6. STRATEGIC ANALYSIS
  • 5.8. MOCA MONTREAL
    • 5.8.1. OVERVIEW
    • 5.8.2. PRODUCT PORTFOLIO
    • 5.8.3. KEY INNOVATION/FOCUS SECTOR
    • 5.8.4. STRATEGIC INITIATIVES
    • 5.8.5. SCOT ANALYSIS
    • 5.8.6. STRATEGIC ANALYSIS
  • 5.9. MEDAVANTE INC
    • 5.9.1. OVERVIEW
    • 5.9.2. PRODUCT PORTFOLIO
    • 5.9.3. KEY INNOVATION/FOCUS SECTOR
    • 5.9.4. STRATEGIC INITIATIVES
    • 5.9.5. SCOT ANALYSIS
    • 5.9.6. STRATEGIC ANALYSIS
  • 5.10. NEUROCOG TRIALS.
    • 5.10.1. OVERVIEW
    • 5.10.2. PRODUCT PORTFOLIO
    • 5.10.3. KEY INNOVATION/FOCUS SECTOR
    • 5.10.4. STRATEGIC INITIATIVES
    • 5.10.5. SCOT ANALYSIS
    • 5.10.6. STRATEGIC ANALYSIS
  • 5.11. NEUROSKY.
    • 5.11.1. OVERVIEW
    • 5.11.2. PRODUCT PORTFOLIO
    • 5.11.3. KEY INNOVATION/FOCUS SECTOR
    • 5.11.4. STRATEGIC INITIATIVES
    • 5.11.5. SCOT ANALYSIS
    • 5.11.6. STRATEGIC ANALYSIS
  • 5.12. PROPHASE, LLC.
    • 5.12.1. OVERVIEW
    • 5.12.2. PRODUCT PORTFOLIO
    • 5.12.3. KEY INNOVATION/FOCUS SECTOR
    • 5.12.4. STRATEGIC INITIATIVES
    • 5.12.5. SCOT ANALYSIS
    • 5.12.6. STRATEGIC ANALYSIS
  • 5.13. PEARSON ASSESSMENT
    • 5.13.1. OVERVIEW
    • 5.13.2. PRODUCT PORTFOLIO
    • 5.13.3. KEY INNOVATION/FOCUS SECTOR
    • 5.13.4. STRATEGIC INITIATIVES
    • 5.13.5. SCOT ANALYSIS
    • 5.13.6. STRATEGIC ANALYSIS
  • 5.14. QUEST DIAGNOSTICS
    • 5.14.1. OVERVIEW
    • 5.14.2. PRODUCT PORTFOLIO
    • 5.14.3. KEY INNOVATION/FOCUS SECTOR
    • 5.14.4. STRATEGIC INITIATIVES
    • 5.14.5. SCOT ANALYSIS
    • 5.14.6. STRATEGIC ANALYSIS
  • 5.15. SAVONIX
    • 5.15.1. OVERVIEW
    • 5.15.2. PRODUCT PORTFOLIO
    • 5.15.3. KEY INNOVATION/FOCUS SECTOR
    • 5.15.4. STRATEGIC INITIATIVES
    • 5.15.5. SCOT ANALYSIS
    • 5.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • TABLE 1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY ASSESSMENT TYPE 2014-2023 ($ MILLION)
  • TABLE 2. GLOBAL PEN AND PAPER-ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 3. GLOBAL HOSTED ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 4. GLOBAL BIOMETRICS ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 5. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY COMPONENT 2014-2023 ($ MILLION)
  • TABLE 6. GLOBAL SOLUTION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 7. GLOBAL SERVICES BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 8. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY APPLICATION 2014-2023 ($ MILLION)
  • TABLE 9. GLOBAL BANKING, FINANCIAL SERVICES, AND INSURANCE BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIALSBY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 11. GLOBAL SCREENING AND DIAGNOSTICS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 12. GLOBAL BRAIN TRAINING BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 13. GLOBAL ACADEMIC RESEARCH BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 14. GLOBAL OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)
  • TABLE 15. NORTH AMERICA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
  • TABLE 16. EUROPE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
  • TABLE 17. ASIA PACIFIC COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
  • TABLE 18. REST OF THE WORLD COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY PEN AND PAPER-ASSESSMENT 2014-2023 ($ MILLION)
  • FIGURE 2. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY HOSTED ASSESSMENT 2014-2023 ($ MILLION)
  • FIGURE 3. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY BIOMETRICS ASSESSMENT 2014-2023 ($ MILLION)
  • FIGURE 4. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SOLUTION 2014-2023 ($ MILLION)
  • FIGURE 5. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SERVICES 2014-2023 ($ MILLION)
  • FIGURE 6. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY CLINICAL TRIALS 2014-2023 ($ MILLION)
  • FIGURE 7. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SCREENING AND DIAGNOSTICS 2014-2023 ($ MILLION)
  • FIGURE 8. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY BRAIN TRAINING 2014-2023 ($ MILLION)
  • FIGURE 9. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY ACADEMIC RESEARCH 2014-2023 ($ MILLION)
  • FIGURE 10. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY OTHERS 2014-2023 ($ MILLION)
  • FIGURE 11. UNITED STATES (U.S.) COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 12. CANADA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 13. UNITED KINGDOM (UK) COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 14. FRANCE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 15. GERMANY COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 16. SPAIN COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 17. ITALY COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 18. ROE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 19. INDIA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 20. CHINA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 21. JAPAN COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 22. KOREA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 23. AUSTRALIA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 24. ROW APAC COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 25. LATIN AMERICA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
  • FIGURE 26. MENA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.